Mangoceuticals, Inc. (MGRX)

0.41USD +5.30% (+0.02)

Over 1M: -16.5%

Style
Area Line Line with markers Steps Candles Hollow candles Bars

Candles and bars need the day’s open, high and low, and need room to be drawn in: past about a year of trading a body is thinner than a hairline, so those three offer the longest window that fits instead.

0.4 0.5 0.6
7 Aug 12 Aug 17 Aug 20 Aug 25 Aug 28 Aug 2 Sep

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '25 — Cost of Revenue: 2.4K Q4 '25 — Cost of Revenue: 8.5K Q1 '26 — Cost of Revenue: 8.2K Q2 '26 — Cost of Revenue: 10.4K 0 2.5K 5K 7.5K 10K 12.5K
Q3 '25 Q4 '25 Q1 '26 Q2 '26
Cost of Revenue Free Cash Flow

How it scores

For a valuation multiple, the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.7
SBC / sales 688.0%
ROIC -77.3%
Accruals -79.1%
Gross margin 54.4%
Asset turnover 0.022×
FCF margin -1234.3%
OCF margin -1234.3%
ROA -106.6%
ROCE -94.5%
ROE -120.6%
Capex / sales —
EBITDA margin —
OCF / EBIT —
OE margin —
Oper. margin —
Profit margin —

2 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

1.0
EV/Sales 27.6×
EV/OE -1.4×
P/B 0.71×
EV/GP 50.6×
FCF yield -43.9%
P/C 38.8×
Div. yield —
EV/EBIT —
Fwd P/E —
P/E —
PEG —

2 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.1
RPO / sales —
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

3.8
ND/EBITDA 0.021
Current ratio 0.18×
Interest cover -116.6×
Cash / Debt 5.1×
Debt / Eq 0.0036×
Debt payback 0.0 yr
Cash runway 0.047 yr
F-score 2.2 pts
Quick ratio 0.17×
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.2
Sales/sh Y/Y -38.9%
Sales Q/Q -59.1%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Sales CAGR 4Y —
Shares change —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.